Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORE
Creative Biolabs offers high-quality custom service covering the entire CAR-T therapy development process to best suit your technical, program and budget requirements which can greatly assist your research, preclinical investigation and clinical stage development.
LEARN MORE
Creative Biolabs offers a broad range of early development service, especially for TCR engineered T cell biomarker identification and selection, design, construction, and analysis.
LEARN MORE
Creative Biolabs now provides world-leading dendritic cell (DC) vaccine development services as part of DC-based immunotherapy to our worldwide clients.
LEARN MORE
We are proud to introduce our innovated TCR-like antibody services, ranging from immunogen production to antibody characterization. We are aiming to accelerate therapeutic antibody drug development for a better tomorrow.
LEARN MORE
Creative Biolabs can provide customers with professional bispecific T-cell receptor (TCR) development service in a de novo manner.
LEARN MORE
Creative Biolabs has established a powerful advanced platform which can be used to test your investigational small molecules against CAR-T and tumor cells through cytokine release assays.
LEARN MORE
Over years in the field of immunotherapy, Creative Biolabs is more than happy to share our technologies, platforms, and experience to facilitate your projects and push the progress towards clinical trials. Please feel free to contact us for more details and our team will get back to you as soon as possible.
LEARN MORE
Creative Biolabs now provides world-leading dendritic cell (DC) vaccine development services to speed up our clients' projects for academic and clinical purposes.
LEARN MORE
Creative Biolabs provides a state-of-the-art mRNA CAR-T Therapy Development Service to address the numerous challenges encountered in traditional CAR-T approaches.
LEARN MORE
Creative Biolabs is dedicated to offering unique insights into cancer immunotherapy through the utilization of monocytes and CAR specificity, thereby unveiling the potential of a new generation of CAR-Mo for the treatmenet of solid tumors.
LEARN MORE
